gma semaglutide New study finds weight loss drugs could reduce risks for some cancers For the first time, Medicare

Patients should be educated on recognising and managing hypoglycaemia, and dose adjustments of concomitant diabetes medications may be necessary

Last reviewed: June 16, 2026 Last updated: June 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Read about their new study: bit.ly/4xBeSJ5 @UTSACAICC | @UTSAResearch What happens when a breakthrough medication goes mainstream

It forces your body to oxidize (burn) stored fat, leading to weight loss

If you find yourself hungrier than usual on the same dose, or if your appetite suppression timeline seems to have shifted, check your vial dates before assuming you need a dose increase

Both semaglutide (the main ingredient in Ozempic) and tirzepatide (the main ingredient in Mounjaro) are being studied for several additional health benefits